Roland E. Schmieder researcher
Schmieder, Roland E.
Schmieder, R.
Schmieder, R. E. (Roland E.)
VIAF ID: 20148207864800342071 (Personal)
Permalink: http://viaf.org/viaf/20148207864800342071
Preferred Forms
-
100 0 _
‡a
Roland E. Schmieder
‡c
researcher
-
100 1 _
‡a
Schmieder, R.
-
100 1 _ ‡a Schmieder, R. E. ‡q (Roland E.)
-
100 1 _
‡a
Schmieder, R. E.
‡q
(Roland E.)
-
100 1 _
‡a
Schmieder, Roland E.
-
100 1 _
‡a
Schmieder, Roland E.
-
100 1 _
‡a
Schmieder, Roland E.
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry |
|
| Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry) |
|
| Bluthochdruck - mein Lernbuch was Sie zum Bluthochdruck und seinen Folgen wissen sollten uns was Sie selbst zur Blutdrucksenkung tun können |
|
| Early vascular parameters in the micro- and macrocirculation in type 2 diabetes |
|
| Einflussmöglichkeiten auf die Progression einer Herz- und Niereninsuffizienz : Wunschvorstellung oder Realität? |
|
| Endorganschädigungen der arteriellen Hypertonie, c1991: |
|
| Guía de práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial (2013) |
|
| Interventional Therapies for Secondary and Essential Hypertension |
|
| The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry |
|
| Renin uptake by the endothelium mediates vascular angiotensin formation |
|
| Reply |
|
| Reproducibility of Kidney Perfusion Measurements With Arterial Spin Labeling at 1.5 Tesla MRI Combined With Semiautomatic Segmentation for Differential Cortical and Medullary Assessment |
|
| Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension" |
|
| Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. |
|
| [Results of an intensive training program for hypertension at the Institute for Preventive Medicine] |
|
| Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment |
|
| Retinal capillary rarefaction in patients with untreated mild-moderate hypertension |
|
| Reversibility of the effects of aliskiren in the renal versus systemic circulation |
|
| [Risks in the development of hypertension] |
|
| The role of nitric oxide in the regulation of glomerular haemodynamics in humans |
|
| The role of statins in the treatment of the metabolic syndrome |
|
| Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia |
|
| Rosuvastatin improves pulse wave reflection by restoring endothelial function |
|
| Rosuvastatin in diabetic hemodialysis patients |
|
| Ruling out secondary causes of hypertension |
|
| Salt. A perpetrator of hypertensive target organ disease? |
|
| Salt and hypertension: going to the heart of the matter |
|
| Salt and hypertension: is salt dietary reduction worth the effort? |
|
| Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure |
|
| Scientific Data and Transparency of Conflict of Interest Are Important, Not Biased Editorial Without Facts. |
|
| Secretory Capacity of Pancreatic Beta-Cells Is Enhanced 6 Months After Renal Denervation in Hypertensive Patients |
|
| Sensory renal innervation: a kidney-specific firing activity due to a unique expression pattern of voltage-gated sodium channels? |
|
| Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. |
|
| Serum uric acid in renovascular hypertension: reduction following surgical correction |
|
| Sex differences in cardiac adaptation to essential hypertension |
|
| Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria |
|
| SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. |
|
| Shared decision-making with hypertensive patients. Results of an implementation in Germany |
|
| Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice |
|
| [Significance of microproteinuria for early detection of hypertension-induced end organ damage] |
|
| Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD. |
|
| Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH. |
|
| Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis |
|
| Standardized stress testing in the cardiovascular laboratory: has it any bearing on ambulatory blood pressure values? |
|
| Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension |
|
| Stress response pattern in obesity and systemic hypertension. |
|
| [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?] |
|
| Subthreshold stimulation of a serotonin 5-HT3 reflex attenuates cardiovascular reflexes |
|
| Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension |
|
| The sympathetic nervous system in chronic kidney disease. |
|
| Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk |
|
| [Systolic or diastolic blood pressure. Which value is more important?] |
|
| Tissue sodium content in hypertension and related organ damage |
|
| Tissue sodium content in patients with type 2 diabetes mellitus |
|
| Tonic Postganglionic Sympathetic Inhibition Induced by Afferent Renal Nerves? |
|
| Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension |
|
| Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). |
|
| Urinary albumin excretion from spot urine samples predict all-cause and stroke mortality in Africans |
|
| Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology |
|
| Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals |
|
| Urinary sodium and potassium excretion and risk of cardiovascular events |
|
| Use of diuretic agents in obese or black patients with systemic hypertension |
|
| Validation of a therapeutic scheme for the treatment of resistant hypertension |
|
| Valsartan and retinal endothelial function in elderly hypertensive patients |
|
| Vascular and renal hemodynamic changes after renal denervation |
|
| Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome |
|
| [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor] |
|
| Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials |
|
| Vitamin C augments the renal response to L-arginine in smokers |
|
| Wall-to-lumen ratio of retinal arterioles: a reproducible, valid and noninvasive approach for evaluation of early arteriolar changes in arterial hypertension in vivo |
|
| Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine |
|
| When is discontinuation of antihypertensive therapy indicated? |
|
| Why in 2016 are patients with hypertension not 100% controlled? A call to action |
|
| Wilder's principle: pre-treatment value determines post-treatment response |
|
| Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control |
|
| The World Hypertension League and International Society of Hypertension call on governments, nongovernmental organizations, and the food industry to work to reduce dietary sodium. |
|
| প্রত্যুত্তর |
|
